In conclusion, our study shows the consistent IL6 overexpression in ESCC cells, suggesting its potential use as a therapeutic target for ESCC, and the paracrine induction of the expression of the antiapoptotic gene BCL3, revealing alterations that may contribute to ESCC development. Here, BCL3 is linked to esophageal squamous cell carcinoma.